Trending Articles
AbCellera’s Breakthroughs in Antibody Discovery for Advanced Cancer Therapeutics
ONCOLife
5 April 2024
Oregon & Lantern Pharma's Strategic AI Collaboration to Enhance Cancer Drug
Digital Health
6 May 2024
TAR-210 Study Shows Promise in Bladder Cancer Treatment with 90% RF Survival Rate
ONCOLife
5 May 2024
FDA Grants Full Approval for Tivdak® to Treat Recurrent or Metastatic Cervical Cancer
FDA & EMA
1 May 2024
GenFleet Receives FDA Approval for P3 Trial of GFH925 in Colorectal Cancer Treatment
FDA & EMA
29 April 2024
Transformative One-Time Gene Therapy: FDA Approves Pfizer's BEQVEZ, for Hemophilia B
FDA & EMA
26 April 2024
A New AI-Driven Drug Discovery Company, Xaira Therapeutics, Launches with $1 Billion
Digital Health
24 April 2024
First-of-Its-Kind Immunotherapy Anktiva Receives FDA Approval for Bladder Cancer
ONCOLife
23 April 2024